Trilogy International Partners (TSE:TRL)‘s stock had its “outperform” rating reissued by equities researchers at Scotiabank in a research report issued to clients and investors on Thursday. They presently have a C$9.50 price objective on the specialty pharmaceutical company’s stock. Scotiabank’s target price would indicate a potential upside of 80.27% from the stock’s current price.

TRL has been the topic of several other research reports. TD Securities cut shares of Trilogy International Partners from a “buy” rating to a “hold” rating and lowered their target price for the company from C$9.50 to C$7.00 in a research note on Friday, November 10th. Royal Bank Of Canada raised their target price on shares of Trilogy International Partners from C$9.00 to C$11.00 and gave the company an “outperform” rating in a research note on Monday, November 13th.

Trilogy International Partners (TRL) traded up C$0.02 during trading on Thursday, reaching C$5.27. 71,500 shares of the company’s stock traded hands, compared to its average volume of 43,454. Trilogy International Partners has a 52-week low of C$5.19 and a 52-week high of C$10.02.

TRADEMARK VIOLATION NOTICE: This report was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this report on another domain, it was illegally stolen and republished in violation of US & international trademark and copyright legislation. The correct version of this report can be viewed at

About Trilogy International Partners

Trilogy International Partners Inc, formerly Alignvest Acquisition Corporation, is a Canada-based wireless telecommunications operator. The Company provides wireless communications services through its subsidiaries in New Zealand and Bolivia. Its subsidiaries include Viva and 2degrees. Viva provides voice and a range of data services to its mobile customers over its third generation (3G)-enabled global system for mobile communications (GSM) and fourth generation (4G) long term evolution (LTE) networks.

Receive News & Ratings for Trilogy International Partners Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trilogy International Partners Inc and related companies with's FREE daily email newsletter.